Bionano Genomics (BNGO) Shares Outstanding (2017 - 2026)

Bionano Genomics has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $11.3 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 263.59% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (up 263.59% YoY) and the FY2025 annual result came in at $5.4 million, up 328.4% from the prior year.
• Shares Outstanding (Entity) rose to $11.3 million in Q1 2026 per BNGO's latest filing, from $5.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $11.3 million in Q1 2026 and troughed at $482910.0 in Q1 2022.
• A 5-year average of $2.2 million and a median of $959175.0 in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) rose 2.62% in 2022, then jumped 328.4% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $495404.0 in 2022, then grew by 14.91% to $569280.0 in 2023, then jumped by 123.26% to $1.3 million in 2024, then surged by 328.4% to $5.4 million in 2025, then jumped by 107.1% to $11.3 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $11.3 million, $5.4 million, and $5.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.